309 related articles for article (PubMed ID: 9693786)
21. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
Matsuoka M; Tani K; Asano S
Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
[TBL] [Abstract][Full Text] [Related]
22. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
Aprelikova O; Xiong Y; Liu ET
J Biol Chem; 1995 Aug; 270(31):18195-7. PubMed ID: 7629134
[TBL] [Abstract][Full Text] [Related]
23. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle regulation during mouse olfactory neurogenesis.
Legrier ME; Ducray A; Propper A; Chao M; Kastner A
Cell Growth Differ; 2001 Dec; 12(12):591-601. PubMed ID: 11751454
[TBL] [Abstract][Full Text] [Related]
25. CDK inhibitors: positive and negative regulators of G1-phase progression.
Sherr CJ; Roberts JM
Genes Dev; 1999 Jun; 13(12):1501-12. PubMed ID: 10385618
[No Abstract] [Full Text] [Related]
26. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
Gray-Bablin J; Rao S; Keyomarsi K
Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
[TBL] [Abstract][Full Text] [Related]
27. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
28. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
Cipriano SC; Chen YQ
Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
[TBL] [Abstract][Full Text] [Related]
29. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ
Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547
[TBL] [Abstract][Full Text] [Related]
30. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.
Hall M; Bates S; Peters G
Oncogene; 1995 Oct; 11(8):1581-8. PubMed ID: 7478582
[TBL] [Abstract][Full Text] [Related]
31. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
32. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
[TBL] [Abstract][Full Text] [Related]
33. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
[TBL] [Abstract][Full Text] [Related]
34. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.
Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG
Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996
[TBL] [Abstract][Full Text] [Related]
35. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.
Matsumura I; Ishikawa J; Nakajima K; Oritani K; Tomiyama Y; Miyagawa J; Kato T; Miyazaki H; Matsuzawa Y; Kanakura Y
Mol Cell Biol; 1997 May; 17(5):2933-43. PubMed ID: 9111365
[TBL] [Abstract][Full Text] [Related]
36. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
Franklin DS; Xiong Y
Mol Biol Cell; 1996 Oct; 7(10):1587-99. PubMed ID: 8898364
[TBL] [Abstract][Full Text] [Related]
37. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
[TBL] [Abstract][Full Text] [Related]
38. Expression and modulation of p42/p44 MAPKs and cell cycle regulatory proteins in rat pancreas regeneration.
Morisset J; Aliaga JC; Calvo EL; Bourassa J; Rivard N
Am J Physiol; 1999 Nov; 277(5):G953-9. PubMed ID: 10564100
[TBL] [Abstract][Full Text] [Related]
39. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
[TBL] [Abstract][Full Text] [Related]
40. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
